Clinical value of wireless pH-monitoring of gastro-esophageal reflux in children before and after proton pump inhibitors

被引：4

作者：

Boström M. ^{[1
]}

Thorsson O. ^{[2
]}

Toth E. ^{[3
]}

Agardh D. ^{[1
]}

机构：

[1] Department of Pediatrics, Unit of Endocrinology and Gastroenterology, Skåne University Hospital, Malmö

[2] Department of Clinical Physiology, Skåne University Hospital, Malmö

[3] Department of Gastroenterology, Endoscopy Unit, Skåne University Hospital, Malmö

来源：

BMC Gastroenterology | / 14卷 / 1期

关键词：

Proton Pump Inhibitor; Esophagitis; Lower Esophageal Sphincter; Acid Exposure; DeMeester Score;

D O I：

10.1186/s12876-014-0225-7

中图分类号：

学科分类号：

摘要：

Background: Wireless pH-monitoring is an accurate method for diagnosing adults with gastroesophageal reflux disease (GERD). The aim of this study was to evaluate the use of the Bravo capsule on children investigated for GERD in terms of safety, tolerability and feasibility before and after administration of proton pump inhibitors. Methods: A Bravo capsule was inserted during upper endoscopy under general anaesthesia or deep sedation with propofol. 48-hour pH-metry was performed in 106 children (50 males, 56 females) at the median age of 11 years (range 17 months-18 years). On the second day of investigation, proton pump inhibitor (PPI) was given at a mean dose of 1.6 mg/kg (SD ±0.6 mg). The definition of GERD was set to a reflux index (RI) of ≥5% and DeMeester score (DMS) ≥14.7. Results: Application of the capsule was successful in 103 of the 106 children (97.2%) and interpretable in 99 of these 103 (96.1%). 49 of the children with interpretable results (49.5%) had GERD according to RI, while 51 (56.7%) had GERD according to DMS. After PPI was given on day 2, RI decreased from a median of 4.9% (range 0.3-63.4%) to 2.2% (0-58.0%), while DMS decreased from a median of 17.6 (range 2.2-207.6) to 8.2 (0.3-178.6), respectively (p < 0.0001). No severe adverse events were reported. Conclusion: Wireless pH-metry is a safe and tolerable method when investigating children for GERD. PPI given on the second day of assessment provides additional information on response to treatment suggesting that pH-metry preferably should be extended to 48 hours. © 2015 Boström et al.

引用

共 34 条

[1]

Vakil N., van Zanten S.V., Kahrilas P., Dent J., Jones R., Global Consensus G., The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus, Am J Gastroenterol, 101, 8, pp. 1900-1920, (2006)

[2]

Sheikh S., Goldsmith L.J., Howell L., Hamlyn J., Eid N., Lung function in infants with wheezing and gastroesophageal reflux, Pediatr Pulmonol, 27, 4, pp. 236-241, (1999)

[3]

Czinn S.J., Blanchard S., Gastroesophageal reflux disease in neonates and infants: when and how to treat, Paediatr Drugs, 15, 1, pp. 19-27, (2013)

[4]

Hegar B., Dewanti N.R., Kadim M., Alatas S., Firmansyah A., Vandenplas Y., Natural evolution of regurgitation in healthy infants, Acta Paediatr, 98, 7, pp. 1189-1193, (2009)

[5]

Kahrilas P.J., Quigley E.M., Clinical esophageal pH recording: a technical review for practice guideline development, Gastroenterology, 110, 6, pp. 1982-1996, (1996)

[6]

Fass R., Hell R., Sampliner R.E., Pulliam G., Graver E., Hartz V., Johnson C., Jaffe P., Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activities, Dig Dis Sci, 44, 11, pp. 2263-2269, (1999)

[7]

Ward E.M., Devault K.R., Bouras E.P., Stark M.E., Wolfsen H.C., Davis D.M., Nedrow S.I., Achem S.R., Successful oesophageal pH monitoring with a catheter-free system, Aliment Pharmacol Ther, 19, 4, pp. 449-454, (2004)

[8]

Wong W.M., Bautista J., Dekel R., Malagon I.B., Tuchinsky I., Green C., Dickman R., Esquivel R., Fass R., Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h oesophageal pH monitoring-a randomized trial, Aliment Pharmacol Ther, 21, 2, pp. 155-163, (2005)

[9]

Croffie J.M., Fitzgerald J.F., Molleston J.P., Gupta S.K., Corkins M.R., Pfefferkorn M.D., Lim J.R., Steiner S.J., Dadzie S.K., Accuracy and tolerability of the Bravo catheter-free pH capsule in patients between the ages of 4 and 18 years, J Pediatr Gastroenterol Nutr, 45, 5, pp. 559-563, (2007)

[10]

Gunnarsdottir A., Stenstrom P., Arnbjornsson E., Wireless esophageal pH monitoring in children, J Laparoendosc Adv Surg Tech A, 18, 3, pp. 443-447, (2008)

← 1 2 3 4 →